MYCN and neuroblastoma: An equal number of datasets derived from patient samples from both categories (three MYCN-amplified neuroblastoma and three non-MYCN-amplified neuroblastoma) that are characterized by similar-low enrichment for immune cells (≤10%) were comparatively studied.